Merck & Co., Inc.
MRK
$92.70
-$0.49-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.74% | 6.51% | 7.15% | 6.11% | 1.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.74% | 6.51% | 7.15% | 6.11% | 1.40% |
| Cost of Revenue | -7.65% | -7.37% | -3.09% | -2.07% | -7.50% |
| Gross Profit | 11.93% | 11.62% | 10.89% | 9.17% | 5.04% |
| SG&A Expenses | 2.20% | 2.15% | -0.84% | -0.12% | 2.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.67% | 20.78% | 14.57% | 14.03% | 12.55% |
| Operating Income | 42.34% | -18.71% | -6.56% | -9.11% | -19.70% |
| Income Before Tax | 955.37% | 84.21% | 181.83% | -74.34% | -88.51% |
| Income Tax Expenses | 85.38% | -44.92% | -34.50% | -27.33% | -21.13% |
| Earnings from Continuing Operations | 4,444.56% | 163.21% | 340.20% | -82.22% | -97.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.33% | -15.38% | -23.08% | 13.33% | -50.00% |
| Net Income | 4,589.59% | 163.63% | 341.53% | -82.30% | -97.49% |
| EBIT | 42.34% | -18.71% | -6.56% | -9.11% | -19.70% |
| EBITDA | 37.06% | -14.62% | -4.70% | -7.63% | -16.86% |
| EPS Basic | 4,574.05% | 163.70% | 340.50% | -82.24% | -97.48% |
| Normalized Basic EPS | 44.19% | -21.05% | -10.68% | -12.42% | -22.16% |
| EPS Diluted | 4,968.12% | 165.15% | 342.38% | -82.57% | -97.68% |
| Normalized Diluted EPS | 44.19% | -21.12% | -10.76% | -12.30% | -22.09% |
| Average Basic Shares Outstanding | -0.09% | -0.16% | -0.09% | 0.04% | 0.19% |
| Average Diluted Shares Outstanding | -0.03% | -0.22% | -0.13% | -0.19% | 0.02% |
| Dividend Per Share | 5.48% | 5.56% | 5.63% | 5.71% | 5.80% |
| Payout Ratio | -0.98% | -0.60% | -0.76% | 4.99% | 41.23% |
